CiplaCPLFY 94 Days Inventory is 267.69 as of Mar. 2026, which is 25% above its 10-year median of 213.85. GuruFocus rates CPLFY with a GF Score™ of 94/100. The stock has 5 warning signs investors should review. Among 916 Drug Manufacturers companies, Cipla ranks worse than 72.38% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cipla's Average Total Inventories for the
three
months ended in Mar. 2026 was $710.71 Mil. Cipla's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $242.27 Mil.
Hence, Cipla's Days Inventory for the
three
months ended in Mar. 2026 was 267.69.
The historical rank and industry rank for Cipla's Days Inventory or its related term are showing as below:
CPLFY'
s Days Inventory Range Over the Past 10 Years
Min: 197.76 Med: 213.85 Max: 230.35
Current: 234.42
During the past 13 years, Cipla's highest Days Inventory was 230.35. The lowest was 197.76. And the median was 213.85.
CPLFY's Days Inventory is ranked worse than 72.38% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs CPLFY: 234.42
Cipla's Days Inventory
increased
from Mar. 2025 (235.19) to Mar. 2026 (267.69).
It might indicate that Cipla's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cipla's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cipla's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.02.
Cipla (OTCPK:CPLFY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cipla's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cipla's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cipla Days Inventory Related Terms
Cipla Days Inventory Historical Data
* Premium members only.
The historical data trend for Cipla's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cipla Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cipla's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cipla's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cipla (CPLFY) has a Days Inventory of 267.69 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cipla and its competitors. This is 25% above median its historical median of 213.85. Over the past decade, Cipla's Days Inventory has ranged from 197.76 to 230.35. According to the industry distribution chart, Cipla ranks #663 out of 916 companies in the Drug Manufacturers industry, placing it in the top 72.4%.
Is Cipla's Days Inventory too high?
Cipla's current Days Inventory of 267.69 is 25% above median its 10-year median of 213.85. Over the past 10 years, this metric has ranged from a low of 197.76 to a high of 230.35. The Drug Manufacturers industry median Days Inventory is 164.43. Cipla's value of 267.69 is 62.8% above this industry median. Based on the distribution chart, Cipla ranks #663 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cipla has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Cipla's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cipla ranks #663 out of 916 companies for Days Inventory. This places Cipla in the lower half of its industry. The industry median Days Inventory is 164.43. Cipla's value of 267.69 is 62.8% above this benchmark. Historically, Cipla's own Days Inventory has ranged from 197.76 to 230.35 over the past decade. While the company's 10-year median is 213.85 vs. the industry median of 164.43, Cipla has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cipla's current Days Inventory of 267.69 is 62.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cipla and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cipla's current Days Inventory is 267.69, which is 25% above median its own 10-year median of 213.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Cipla (CPLFY) has a current Days Inventory of 267.69. The current Days Inventory is 267.69, which is 25% above median its 10-year median of 213.85 and 62.8% above the Drug Manufacturers industry median of 164.43. Cipla's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cipla (CPLFY), the current Days Inventory is 267.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPLFY has been successfully added to your 